TOP NEWS NIPRD flags Nigeria’s reliance on single WHO-prequalified antimalarial product nationwide The National Institute for Pharmaceutical Research and Development (NIPRD) has raised concerns over Nigeria’s heavy reliance on a single World Ijeoma Nwanosike Read More
Role of patent waivers and compulsory licensing in aiding access to COVID-19 vaccines Davidson Oturu and Obi Adigwe Read More
Developing homegrown remedies for COVID-19, other viral infections Chukwuma Muanya and Nkechi Onyedika-Ugoeze Read More